Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Humatrope Treatment and Long-term Growth in Girls With Turner Syndrome
2016-001502-42Phase 4
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of somatropin in Turner syndrome (TS) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Adult height at the end of growth.
02
Drugs
somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on 2016-001502-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001502-42.